BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8989239)

  • 1. High expression of the POU factor Brn3a in aggressive neuroendocrine tumors.
    Leblond-Francillard M; Picon A; Bertagna X; de Keyzer Y
    J Clin Endocrinol Metab; 1997 Jan; 82(1):89-94. PubMed ID: 8989239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
    de Keyzer Y; Lenne F; Auzan C; Jégou S; René P; Vaudry H; Kuhn JM; Luton JP; Clauser E; Bertagna X
    J Clin Invest; 1996 Mar; 97(5):1311-8. PubMed ID: 8636444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of genes associated with the corticotroph phenotype in bronchial carcinoid tumors.
    Pascual-Le Tallec L; Dulmet E; Bertagna X; de Keyzer Y
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5015-22. PubMed ID: 12414866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ; Melmed S
    Endocrinology; 1999 Apr; 140(4):1559-66. PubMed ID: 10098488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.
    de Keyzer Y; René P; Beldjord C; Lenne F; Bertagna X
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):475-82. PubMed ID: 9876345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors.
    Raffin-Sanson ML; Massias JF; Dumont C; Raux-Demay MC; Proeschel MF; Luton JP; Bertagna X
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4272-7. PubMed ID: 8954027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
    Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues.
    Lloyd RV; Jin L; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
    Lab Invest; 1993 Nov; 69(5):570-5. PubMed ID: 8246449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs.
    Vallette-Kasic S; Figarella-Branger D; Grino M; Pulichino AM; Dufour H; Grisoli F; Enjalbert A; Drouin J; Brue T
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3050-6. PubMed ID: 12843142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid prevents experimental Cushing syndrome.
    Páez-Pereda M; Kovalovsky D; Hopfner U; Theodoropoulou M; Pagotto U; Uhl E; Losa M; Stalla J; Grübler Y; Missale C; Arzt E; Stalla GK
    J Clin Invest; 2001 Oct; 108(8):1123-31. PubMed ID: 11602619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable modes of proopiomelanocortin gene transcription in human tumors.
    de Keyzer Y; Bertagna X; Luton JP; Kahn A
    Mol Endocrinol; 1989 Jan; 3(1):215-23. PubMed ID: 2536890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of corticotropin-releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro.
    Suda T; Tozawa F; Yamada M; Ushiyama T; Tomori N; Sumitomo T; Nakagami Y; Demura H; Shizume K
    J Clin Invest; 1988 Jul; 82(1):110-4. PubMed ID: 2839542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression.
    Pellegrini-Bouiller I; Morange-Ramos I; Barlier A; Gunz G; Figarella-Branger D; Cortet-Rudelli C; Grisoli F; Jaquet P; Enjalbert A
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3390-6. PubMed ID: 8784102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antisense DNA on POMC mRNA and ACTH levels in cultured human corticotroph adenoma cells.
    Woloschak M; Post K; Roberts JL
    J Endocrinol Invest; 1994 Nov; 17(10):817-9. PubMed ID: 7699217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prop-1 gene expression in human pituitary tumors.
    Nakamura S; Ohtsuru A; Takamura N; Kitange G; Tokunaga Y; Yasunaga A; Shibata S; Yamashita S
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2581-4. PubMed ID: 10404841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proopiomelanocortin gene expression in normal and tumoral human lung.
    Texier PL; de Keyzer Y; Lacave R; Vieau D; Lenne F; Rojas-Miranda A; Verley JM; Luton JP; Kahn A; Bertagna X
    J Clin Endocrinol Metab; 1991 Aug; 73(2):414-20. PubMed ID: 1856267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the prohormone convertase PC2 correlates with the presence of corticotropin-like intermediate lobe peptide in human adrenocorticotropin-secreting tumors.
    Vieau D; Seidah NG; Mbikay M; Chrétien M; Bertagna X
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1503-6. PubMed ID: 7962350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.